IDYA — Ideaya Biosciences Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Ideaya Biosciences Inc

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoa… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$29.35
Market Cap$2.61B
Float87.0M
Shares Outstanding87.9M
P/E (Forward)4.65
Price/Sales (TTM)11.56
vs. Analyst Target+79.7% to analyst PT
Profit Margin-62.17%
Operating Margin (TTM)-1654.63%
Revenue (TTM)$225M
Dividend RateNone
Analyst Target Price$52.75 (13 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $19.5M -$32.3M $19.5M -$34.0M
2021 $27.9M -$47.5M $27.9M -$48.5M
2022 $50.9M -$54.8M $50.9M -$60.4M
2023 $23.4M -$113M $19.4M -$109M
2024 $7.0M -$274M $3.2M -$271M
2025 $219M -$114M $214M -$155M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$77.5M
Sep 2025 $208M $119M
Dec 2025 $10.9M -$83.3M
Mar 2026 $6.6M -$98.5M

Ownership & Float

Insider Ownership2.4%
Institutional Ownership109.8%
Short Float13.5%
% of All Funds Holding2.86%
Number of Funds Holding235

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$30.15Near-term / short-term trend
Weekly40-Week SMA$31.12Medium-term trend
Weekly80-Week SMA$26.48Cyclical trend (business cycle)
Weekly200-Week SMA$27.12Secular trend (multi-year)
Monthly10-Month SMA$31.00Near-term monthly trend
Monthly20-Month SMA$26.89Medium-term monthly trend
Monthly40-Month SMA$29.14Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$33.50 resistance 1.55x 0 months ago
$27.20 support 1.20x 6 months ago
$16.40 support 1.85x 12 months ago

Historical Earnings Reactions (29 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.03% 0.46% 62.07% 4.59% -8.44%
1 Day -0.84% -0.21% 48.28% 6.44% -8.00%
1 Week -0.22% 1.24% 58.62% 11.27% -19.41%
2 Weeks 1.27% 1.27% 58.62% 23.52% -22.57%
1 Month 3.15% 6.61% 53.57% 27.43% -21.01%

Next earnings: July 24, 2026 (58 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan1.9%42.9%7
Feb-5.6%57.1%7
Mar-10.6%28.6%7
Apr6.2%42.9%7
May17.4%50.0%6
Jun8.8%71.4%7
Jul2.7%57.1%7
Aug-3.2%28.6%7
Sep11.3%71.4%7
Oct-5.2%42.9%7
Nov11.8%85.7%7
Dec1.7%57.1%7

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.66% 51.7% 329
Tuesday 0.31% 51.4% 364
Wednesday 0.08% 48.3% 360
Thursday -0.18% 46.3% 352
Friday -0.04% 51.1% 354

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 109.8%

Insider Transactions — Smart Summary

Total insider ownership: 2.4%

Founder-led management: Yujiro S. Hata (Founder, President, Chief Executive Officer & Director)

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change50,000
% of Float0.1%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Stein Jeffrey +$1.6M 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-02 Stein Jeffrey +$1.6M Transaction at $32.96, now -10.9%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Ideaya Biosciences Inc (IDYA) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for IDYA on Trend Edge →